Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Gordon

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
BMJ Open|August 7, 2019
Evolution of the burden of active hepatitis C virus infection in England from September 2015 to September 2016: a repeated cross-sectional analysisLaure Lacoin, Michael Hurst, Nathan R Hill, et al.
Biomicrofluidics|August 21, 2009
Rapid on-chip genetic detection microfluidic platform for real world applicationsSatyajyoti Senapati, Andrew R Mahon, Jason Gordon, et al.
BMC Health Services Research|December 10, 2015
Costs and advance directives at the end of life: a case of the 'Coaching Older Adults and Carers to have their preferences Heard (COACH)' trialBillingsley Kaambwa, Julie Ratcliffe, Sandra L Bradley, et al.
Pharmacoeconomics|April 7, 2020
Estimating the Value of New Antimicrobials in the Context of Antimicrobial Resistance: Development and Application of a Dynamic Disease Transmission ModelJason Gordon, Oliver Darlington, Phil McEwan, et al.
Plos One|November 2, 2019
Predicting atrial fibrillation in primary care using machine learningNathan R Hill, Daniel Ayoubkhani, Phil McEwan, et al.
Nature Medicine|May 12, 2026
Framework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity (EASO): 2026 updateAndreea Ciudin, Jennifer L Baker, Andrej Belančić, et al.
European Journal of Heart Failure|March 16, 2023
Patient-reported outcome measures and patient engagement in heart failure clinical trials: multi-stakeholder perspectivesFaiez Zannad, Jacqueline Alikhaani, Sadegh Alikhaani, et al.
BMC Primary Care|January 3, 2024
Undertaking multi-centre randomised controlled trials in primary care: learnings and recommendations from the PULsE-AI trial researchersKevin G Pollock, Carissa Dickerson, Manjit Kainth, et al.
Journal of Medical Economics|July 14, 2022
Identification of undiagnosed atrial fibrillation using a machine learning risk prediction algorithm and diagnostic testing (PULsE-AI) in primary care: cost-effectiveness of a screening strategy evaluated in a randomized controlled trial in EnglandNathan R Hill, Lara Groves, Carissa Dickerson, et al.
Contemporary Clinical Trials|October 22, 2020
Identification of undiagnosed atrial fibrillation patients using a machine learning risk prediction algorithm and diagnostic testing (PULsE-AI): Study protocol for a randomised controlled trialNathan R Hill, Chris Arden, Lee Beresford-Hulme, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
BMJ Open|August 7, 2019
Evolution of the burden of active hepatitis C virus infection in England from September 2015 to September 2016: a repeated cross-sectional analysisLaure Lacoin, Michael Hurst, Nathan R Hill, et al.
Biomicrofluidics|August 21, 2009
Rapid on-chip genetic detection microfluidic platform for real world applicationsSatyajyoti Senapati, Andrew R Mahon, Jason Gordon, et al.
BMC Health Services Research|December 10, 2015
Costs and advance directives at the end of life: a case of the 'Coaching Older Adults and Carers to have their preferences Heard (COACH)' trialBillingsley Kaambwa, Julie Ratcliffe, Sandra L Bradley, et al.
Pharmacoeconomics|April 7, 2020
Estimating the Value of New Antimicrobials in the Context of Antimicrobial Resistance: Development and Application of a Dynamic Disease Transmission ModelJason Gordon, Oliver Darlington, Phil McEwan, et al.
Plos One|November 2, 2019
Predicting atrial fibrillation in primary care using machine learningNathan R Hill, Daniel Ayoubkhani, Phil McEwan, et al.
Nature Medicine|May 12, 2026
Framework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity (EASO): 2026 updateAndreea Ciudin, Jennifer L Baker, Andrej Belančić, et al.
European Journal of Heart Failure|March 16, 2023
Patient-reported outcome measures and patient engagement in heart failure clinical trials: multi-stakeholder perspectivesFaiez Zannad, Jacqueline Alikhaani, Sadegh Alikhaani, et al.
BMC Primary Care|January 3, 2024
Undertaking multi-centre randomised controlled trials in primary care: learnings and recommendations from the PULsE-AI trial researchersKevin G Pollock, Carissa Dickerson, Manjit Kainth, et al.
Journal of Medical Economics|July 14, 2022
Identification of undiagnosed atrial fibrillation using a machine learning risk prediction algorithm and diagnostic testing (PULsE-AI) in primary care: cost-effectiveness of a screening strategy evaluated in a randomized controlled trial in EnglandNathan R Hill, Lara Groves, Carissa Dickerson, et al.
Contemporary Clinical Trials|October 22, 2020
Identification of undiagnosed atrial fibrillation patients using a machine learning risk prediction algorithm and diagnostic testing (PULsE-AI): Study protocol for a randomised controlled trialNathan R Hill, Chris Arden, Lee Beresford-Hulme, et al.
Pageof 7